Structure (Dexlansoprazole Delayed Release Capsules 1)
Dexlansoprazole Capsule, Delayed Release
Product Images NDC 72162-2214
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 72162-2214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Dexlansoprazole Delayed Release Capsules 2)
This text appears to be a representation of plasma concentration (in ng/mL) for dexlansoprazole at different dosage levels. The dosages mentioned are 30 mg and 60 mg.*
Label (Lbl721622214)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
